Management of COVID-19: A Clinical Nursing Practice Guideline for Pregnant Women Undergoing a Cesarean Section

Coronavirus disease (COVID-19) has been declared a pandemic respiratory disease. Pregnant women infected with COVID-19 may deliver by caesarean section when there are medical reasons that guarantee the safety of the mother and baby. This leads to the development of a strong guidelines for pregnant women infected with the COVID-19 virus undergoing caesarean section.

This article is intended to develop a clinical nursing practice guideline for the prevention and control of COVID-19 infection between healthcare providers and COVID-19 infected pregnant women undergoing caesarean section and assess the feasibility of CNPG implementation.

An action research was employed between October to March 2021. This study was constructed with the NHMRC model involving the following steps: 1) determining the needs and scope of the guide; 2) a multidisciplinary committee meeting to oversee the development of the guideline; 3) set the objectives and target groups of the guideline; 4) the CNPG formula; 5) implement the guideline; and 6) documented as a guideline. We evaluated the feasibility of CNPG implementation.

Four themes in the needs for and scope of the guideline were used to create the guideline. Guidelines for the prevention and control of COVID-19 infection related to medical care from pregnant women with COVID -19 who have undergone cesarean section, there are 3 phases: peri-operative period, intra-operative period, and postoperative period. After using CNPG in three pregnant women with coronavirus infection undergoing caesarean section. It was a pilot study to test the feasibility of CNPG implementation. Overall feasibility was high (M= 2.69, SD = 0.35, p <0.05).

The results of this study can lead to improve the quality of care for prevention and control of healthcare-associated COVID-19 infection from COVID-19 pregnant women undergoing a cesarean section during the COVID-19 spreading era.

The CNPG has been presented to be beneficial. However, it is necessary to determine the rate of healthcare-associated COVID-19 infection in COVID-19 pregnant women undergoing a cesarean section with an acceptable sample size.